首页> 外文OA文献 >Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel, New York City, New York, USA, May–July 2020
【2h】

Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel, New York City, New York, USA, May–July 2020

机译:第一次响应者和公共安全人员的SARS-COV-2抗体患病率,纽约市,美国纽约,5月20日至7月

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We conducted a serologic survey in public service agencies in New York City, New York, USA, during May–July 2020 to determine prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among first responders. Of 22,647 participants, 22.5% tested positive for SARS-CoV-2–specific antibodies. Seroprevalence for police and firefighters was similar to overall seroprevalence; seroprevalence was highest in correctional staff (39.2%) and emergency medical technicians (38.3%) and lowest in laboratory technicians (10.1%) and medicolegal death investigators (10.8%). Adjusted analyses demonstrated association between seropositivity and exposure to SARS-CoV-2–positive household members (adjusted odds ratio [aOR] 3.52 [95% CI 3.19–3.87]), non-Hispanic Black race or ethnicity (aOR 1.50 [95% CI 1.33–1.68]), and severe obesity (aOR 1.31 [95% CI 1.05–1.65]). Consistent glove use (aOR 1.19 [95% CI 1.06–1.33]) increased likelihood of seropositivity; use of other personal protective equipment had no association. Infection control measures, including vaccination, should be prioritized for frontline workers.
机译:我们在美国纽约纽约纽约市纽约市的公共服务机构进行了血清学调查,在2020年5月至7月期间,在第一个受访者中确定严重急性呼吸综合征冠状病毒2(SARS-COV-2)感染的患病率。 22,647名参与者,22.5%对SARS-COV-2特异性抗体进行了阳性。警察和消防员的Seroprevalence类似于整体血清透视;惩教人员(39.2%)和紧急医疗技术人员(38.3%)和实验室技术人员(10.1%)和药物死亡调查人员(10.8%)中最低。调整后的分析证明了血清阳性和暴露于SARS-COV-2阳性家庭成员之间的关联(调整后的赔率比[AOR] 3.52 [95%CI 3.19-3.87]),非西班牙裔人或种族(AOR 1.50 [95%CI [95% 1.33-1.68])和严重肥胖症(AOR 1.31 [95%CI 1.05-1.65])。一致的手套使用(AOR 1.19 [95%CI 1.06-1.33])增加了血清阳性的可能性;使用其他个人防护设备没有关联。应为前线工人优先考虑感染控制措施,包括疫苗接种。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号